Liqiang Xu
Papers
1
Total Citations
2
H-Index
1
About
Dr. Liqiang Xu is a pioneering thoracic surgeon whose research focuses on advancing surgical techniques for esophageal cancer, particularly through the integration of robotic-assisted surgery and total mesoesophageal excision (TME). His landmark 2026 study, which has already garnered early citations, systematically compared robot-assisted esophagectomy with TME against conventional minimally invasive esophagectomy (MIE), demonstrating superior clinical outcomes in terms of lymph node dissection and perioperative safety. This work represents a significant contribution to the field, as it provides robust evidence for the oncological benefits of combining robotic precision with the TME principle—a concept that aims to achieve more complete tumor resection by removing the mesoesophageal envelope. Dr. Xu’s research directly addresses critical gaps in esophageal cancer surgery, offering a pathway to improved survival and reduced recurrence rates. His findings have been recognized as a potential new standard for minimally invasive approaches, influencing surgical protocols and inspiring further investigation into robotic-assisted oncologic resections. Through his meticulous comparative analyses, Dr. Xu continues to shape the future of esophageal cancer treatment, making him a key figure in surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1